Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$43.99 USD
+0.29 (0.66%)
Updated May 3, 2024 04:00 PM ET
After-Market: $43.92 -0.07 (-0.16%) 6:30 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 421 - 437 ( 437 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
1Q Revenue and EPS Up Despite Health Care Legislation. Important New Product Approved
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
4Q Revenue Up 2%, But a Higher Tax Rate Led to Flat EPS. Pipeline Products Progressing.
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
3Q Revenue a Little Light. Expense Management Pushed EPS Well Ahead of Estimates.
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Second quarter revenue from continuing operations
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
1Q EPS Exceeded Estimates on Double-digit Revenue Growth and Margin Improvement
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Biotech Balance Sheet
Provider: Merriman Curhan Ford & Co.
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Biotech Balance Sheet
Provider: Merriman Curhan Ford & Co.
Company: Bristol Myers Squibb Company
Industry: Medical - Drugs
Biotech Balance Sheet.
Provider: MERRIMAN CURHAN FORD & CO.
Company: Bristol Myers Squibb Company
Industry: Medical - Drugs
Company: Bristol Myers Squibb Company
Industry: Medical - Drugs
Strong Results from BMYs Core Pharmaceuticals Business. Last of the Non-drug Units Divested
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S